Glipizide
Product Images NDC 66336-269

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 66336-269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 66336-0269-xx (Ndc 66336 0269 Xx Patheon)

Label for Glipizide ER 10 mg tablets from Dispensing Solutions, Inc. Shows extended-release tablets with NDC 66336-0269. The label includes manufacturer information for Patheon Pharmaceuticals Inc., directions for oral use once daily with breakfast, warnings to avoid crushing or dividing tablets, and storage instructions. The packaging also displays lot and expiration placeholders and barcode details.*

FDA Label Image

Structural Formula For Glipizide (Glipizide Extended Release Tablet 1)

Chemical structure diagram of the active ingredient in Glipizide ER. The structure shows molecular components including ring systems and functional groups consistent with glipizide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.